Healthcare & Life Sciences Research · Independent · Evidence-Based

Rigorous Analysis for Healthcare Decision-Makers

Independent research across therapeutics, medical devices, digital health, and clinical operations — evidence-based intelligence for the life sciences industry.

✓ No pay-to-rank📋 Published methodology👤 Named reviewers↺ Open corrections
LIVE
GLP-1 Market Expansion: $87B projected by 2028 across diabetes and obesityAI Diagnostics FDA Clearances: 47 new AI/ML-enabled devices approved in H1 2026Clinical Trial Decentralization: 38% of Phase III trials now include remote monitoringGene Therapy Pipeline: 2,400+ active trials globally, up 28% year-over-yearDigital Therapeutics: Reimbursement pathways expanding in 12 new marketsPrecision Medicine: Genomic testing adoption reaches 34% in US oncology practicesGLP-1 Market Expansion: $87B projected by 2028 across diabetes and obesityAI Diagnostics FDA Clearances: 47 new AI/ML-enabled devices approved in H1 2026Clinical Trial Decentralization: 38% of Phase III trials now include remote monitoringGene Therapy Pipeline: 2,400+ active trials globally, up 28% year-over-yearDigital Therapeutics: Reimbursement pathways expanding in 12 new marketsPrecision Medicine: Genomic testing adoption reaches 34% in US oncology practices
280+Clinical Analyses
65Therapeutic Areas
1,200+Trial Evaluations
92%Forecast Accuracy
Featured Report

Digital Health Platform Benchmark 2026

Evaluation of 32 digital health platforms across clinical validation, interoperability, patient outcomes, and regulatory compliance.

Research Team48 pages24 vendors scoredJul 2026
Read the Report
Healthcare & Life Sciences

Digital Health Platform Benchmark 2026

Clinical Validation
74%
Interoperability
58%
Patient Outcomes
81%
Regulatory Compliance
67%

Recent Healthcare & Life Sciences Research

View all insights →
Market Report

Sample Research Report

A placeholder research article demonstrating the content schema and publishing workflow.

Research Team · Aug 2026